Barclays PLC Portfolio Holdings

Barclays PLC

  • $436 Billion
  • Q2 2025

Barclays PLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $436 Billion distributed in 12350 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Microsoft Corp with a value of $17.4B, Nvidia Corp with a value of $15.9B, Apple Inc. with a value of $9.34B, Amazon Com Inc with a value of $7.98B, and Tesla, Inc. with a value of $6.51B.

Examining the 13F form we can see an increase of $184B in the current position value, from $252B to 436B.

Barclays PLC is based out at London, X0

Below you can find more details about Barclays PLC portfolio as well as his latest detailed transactions.

Portfolio value $436 Billion
ETFs: $158 Billion
Technology: $99.7 Billion
Consumer Cyclical: $34.9 Billion
Financial Services: $33.3 Billion
Communication Services: $27 Billion
Industrials: $20.8 Billion
Healthcare: $20 Billion
Consumer Defensive: $11.9 Billion
Other: $21.9 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
Bill Holdings Inc
-
$40,000 0.0% of portfolio
-
Q2 2025 New
$6.9B
$4.79 Million 0.0% of portfolio
19,848
Q2 2025 Reduced 33.51%
$2.02B
$20 Million 0.0% of portfolio
389,157
Q2 2025 Added 17.32%
Bioage Labs Inc
-
$165,000 0.0% of portfolio
-
Q2 2025 Added 213.99%
$1.43B
$7.21 Million 0.0% of portfolio
804,112
Q2 2025 Added 99.73%
$269M
$0 0.0% of portfolio
180
Q2 2025 Reduced 99.68%
Biohaven LTD
-
$4.9 Million 0.0% of portfolio
-
Q2 2025 Added 112.18%
$1.1B
$1.6 Million 0.0% of portfolio
74,029
Q2 2025 Added 53.01%
Biomarin Pharmaceutical Inc
-
$361,000 0.0% of portfolio
-
Q2 2025 Added 2.94%
$57.4M
$7,000 0.0% of portfolio
3,893
Q2 2025 Reduced 88.44%
Biomx Inc
-
$11,000 0.0% of portfolio
-
Q3 2024 New
$23.8B
$2.67 Million 0.0% of portfolio
25,094
Q2 2025 Reduced 78.9%
Biosig Technologies Inc
-
$10,000 0.0% of portfolio
-
Q2 2025 New
$25.7M
$350,000 0.0% of portfolio
87,066
Q2 2025 Added 28.51%
$442M
$583,000 0.0% of portfolio
88,108
Q2 2025 Added 87.16%
Bioxcel Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2025 Reduced 99.58%
$242M
$1.54 Million 0.0% of portfolio
704,000
Q2 2025 Added 193.14%
$508M
$74,000 0.0% of portfolio
89,451
Q2 2025 Reduced 7.18%
$729M
$2.21 Million 0.0% of portfolio
49,499
Q2 2025 Added 61.88%
$13.4B
$11.7 Million 0.0% of portfolio
108,786
Q2 2025 Reduced 31.69%
Bk Technologies Corporation
-
$227,000 0.0% of portfolio
-
Q2 2025 Added 5,549.41%
Bkv Corp
-
$758,000 0.0% of portfolio
-
Q2 2025 Added 72.4%
$120M
$74,000 0.0% of portfolio
29,870
Q2 2025 Reduced 55.18%
$3.81B
$10.8 Million 0.0% of portfolio
192,694
Q2 2025 Added 12.21%
$2.72B
$21,000 0.0% of portfolio
1,632
Q2 2025 Reduced 25.24%
$3.67B
$5.32 Million 0.0% of portfolio
82,897
Q2 2025 Added 34.37%
$2.32B
$950,000 0.0% of portfolio
207,278
Q2 2025 Added 76.84%
$0
$3,000 0.0% of portfolio
346
Q2 2025 New
Blacksky Technology Inc
-
$1.04 Million 0.0% of portfolio
-
Q2 2025 Added 93.74%
$3.31B
$6.08 Million 0.0% of portfolio
316,008
Q2 2025 Added 44.08%
$4.55B
$271,000 0.0% of portfolio
8,800
Q1 2025 Reduced 80.28%
$307M
$803,000 0.0% of portfolio
199,458
Q2 2025 Added 31.68%
$942M
$1.71 Million 0.0% of portfolio
517,042
Q2 2025 Added 41.17%
$69.2M
$16,000 0.0% of portfolio
17,422
Q2 2025 Reduced 88.38%
$598M
$2.02 Million 0.0% of portfolio
234,505
Q2 2025 Added 111.62%
$1.8B
$2.72 Million 0.0% of portfolio
62,989
Q2 2025 Added 46.06%
$261M
$297,000 0.0% of portfolio
31,051
Q2 2025 Added 57.09%
$5.27B
$8.92 Million 0.0% of portfolio
621,854
Q2 2025 Added 153.98%
$8.2B
$12 Million 0.0% of portfolio
625,030
Q2 2025 Added 45.57%
Blue Owl Technology Fin Corp
-
$8,000 0.0% of portfolio
-
Q2 2025 New
$79M
$408,000 0.0% of portfolio
113,624
Q2 2025 Added 160.68%
Bluebird Bio Inc
-
$0 0.0% of portfolio
-
Q2 2025 Reduced 99.99%
$730M
$5.16 Million 0.0% of portfolio
69,347
Q2 2025 Added 0.98%
$0
$61,000 0.0% of portfolio
4,900
Q2 2023 Reduced 28.55%
Bofa Fin LLC
-
$4,000 0.0% of portfolio
-
Q2 2025 New
$3.17B
$11.3 Million 0.0% of portfolio
130,317
Q2 2025 Added 62.49%
$7.41B
$1.78 Million 0.0% of portfolio
18,250
Q2 2025 Reduced 37.02%
Bolt Biotherapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2025 New
$5.34B
$13.7 Million 0.0% of portfolio
90,010
Q2 2025 Added 88.34%

Summary

  • Portfolio
  • No. of Stocks 12,350
  • Current Value $436 Billion
  • Prior Value $252 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR/A
  • Activity in Q2 2025
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email